Overview
Ahmed El Bastawisy practices practicing medicine in Cairo, Egypt.
His clinical expertise encompasses Lung Cancer, Classical Hodgkin Lymphoma, and Triple-Negative Breast Cancer.
He is actively involved in clinical research, co-authoring 8 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Ahmed El Bastawisy
Is Ahmed El Bastawisy a top-rated expert for Lung Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Ahmed El Bastawisy is classified as an Experienced expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Ahmed El Bastawisy participate in research or clinical trials?
Yes. Ahmed El Bastawisy has published 8 articles and abstracts on conditions like Lung Cancer. You can view a list of Ahmed El Bastawisy's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Classical Hodgkin LymphomaMr. El Bastawisy isExperienced. Learn about Classical Hodgkin Lymphoma.
- Lung CancerMr. El Bastawisy isExperienced. Learn about Lung Cancer.
- Triple-Negative Breast CancerMr. El Bastawisy isExperienced. Learn about Triple-Negative Breast Cancer.